Warning: count(): Parameter must be an array or an object that implements Countable in /home/customer/www/drugtrialsformoney.com/public_html/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 373

Infections and Infectious Diseases

Trial to Reduce Antimicrobial Use In Nursing Home Residents With Alzheimer’s Disease and Other Dementias

Conditions:   Dementia;   Infection, Bacterial
Intervention:   Behavioral: TRAIN-AD
Sponsor:   Hebrew Rehabilitation Center, Boston
Not yet recruiting – verified August 2017
ClinicalTrials.gov: Infections_Infectious_Diseases | Recruiting, Not yet recruiting, Available Studies | United States | Studies received in the last 100 days

August 10, 2017 / by / in
Evaluating the Infectivity, Safety, and Immunogenicity of the Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccines RSV ΔNS2/Δ1313/I1314L or RSV 276 in RSV-Seronegative Infants 6 to 24 Months of Age

Condition:   Respiratory Syncytial Virus Infections
Interventions:   Biological: RSV ΔNS2/Δ1313/I1314L;   Biological: RSV 276;   Biological: Placebo
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting – verified August 2017
ClinicalTrials.gov: Infections_Infectious_Diseases | Recruiting, Not yet recruiting, Available Studies | United States | Studies received in the last 100 days

August 8, 2017 / by / in
Polyclonal Regulatory T Cells (PolyTregs) for Pemphigus

Conditions:   Pemphigus Foliaceus;   Pemphigus Vulgaris
Interventions:   Biological: Cohort 1: 2.5 x 10^8 PolyTregs;   Biological: Cohort 2: 10×10^8 PolyTregs
Sponsors:   National Institute of Allergy and Infectious Diseases (NIAID);   Autoimmunity Centers of Excellence
Not yet recruiting – verified August 2017
ClinicalTrials.gov: Infections_Infectious_Diseases | Recruiting, Not yet recruiting, Available Studies | United States | Studies received in the last 100 days

August 6, 2017 / by / in
Safety and Pharmacokinetic Study of Dapivirine Gel (0.05%) Administered Rectally to HIV-1 Seronegative Adults

Condition:   HIV Infections
Interventions:   Drug: Dapivirine gel;   Drug: Placebo gel
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting – verified August 2017
ClinicalTrials.gov: Infections_Infectious_Diseases | Recruiting, Not yet recruiting, Available Studies | United States | Studies received in the last 100 days

August 5, 2017 / by / in
Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection

Conditions:   HSIL;   HSIL of Cervix;   High-Grade Squamous Intraepithelial Lesions;   High-grade Cervical Intraepithelial Neoplasia;   Human Papilloma Virus;   Cervical Cancer;   Cervical Intraepithelial Neoplasia;   Cervical Neoplasm;   Cervical Dysplasia;   CIN
Intervention:   Drug: ABI-1968
Sponsor:   Antiva Biosciences
Not yet recruiting – verified August 2017
ClinicalTrials.gov: Infections_Infectious_Diseases | Recruiting, Not yet recruiting, Available Studies | United States | Studies received in the last 100 days

August 3, 2017 / by / in
Evaluating the Safety and Immunogenicity of pDNA Vaccines Expressing HIV M Group p24^Gag Conserved Elements and/or p55^Gag, Administered With IL-12 pDNA by Intramuscular Electroporation, in Healthy, HIV-Uninfected Adults

Condition:   HIV Infections
Interventions:   Biological: p24CE1/2 pDNA Vaccine;   Biological: p55^gag pDNA Vaccine;   Biological: IL-12 pDNA Adjuvant;   Biological: Placebo;   Device: Ichor Medical Systems Intramuscular TriGrid Delivery System (TDS-IM) electroporation (EP) device
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting – verified July 2017
ClinicalTrials.gov: Infections_Infectious_Diseases | Recruiting, Not yet recruiting, Available Studies | United States | Studies received in the last 100 days

August 2, 2017 / by / in